SpecStream

Data / Form D filings / REVBIO, INC.

REVBIO, INC.: Form D filing

REVBIO, INC., a health care company in Lowell, MA, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $15 million sold of a $15 million offering to 72 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
600 SUFFOLK STREET SUITE 250, Lowell, MA, 01854
Phone
(617) 947-6246
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1763734

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 2Amendment$15,000,000$14,988,157$11,84372Apr 24sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
BRIAN HESSExecutive Officer, Director
GEORGE KAYDirector
D. GRAYSON ALLENExecutive Officer, Director
KEVIN FOLEYDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Sep 28 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what REVBIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.